N-Heterocyclic carbenes (NHCs) complexes represent new anticancer agents, normally with low toxicity profiles, and they provide a range of versatile structures for targeted biological applications [1]. In this field novel 1,3-symmetrically and 1,3-unsymmetrically substituted NHCs precursors have been synthesized (Figure 1) and used in the synthesis of multicharged metal-NHC complexes. In addition the novel NHC ligand precursor 1,4-bis(4-nitrobenzyl)-1H-1,2,4-triazol-4-ium bromide, [HTz(pNO2Bz)2]Br (Figure 1), has been synthesized and used in the synthesis of the corresponding metal complexes M[Tz(pNO2Bz)2]Br (M = Cu(I), Ag(I) or Au(I)). The cytotoxic properties of the NHCs complexes and of the corresponding uncoordinated ligands have been assessed in various human cancer cell lines, including cisplatin sensitive and resistant cells. Moreover, a detailed analysis of their molecular and cellular pharmacology has been performed in order to elucidate the role of the metallic core in determining the biological properties of this class of NHCs complexes. In particular, the ability of triazolium NHC compounds to hamper mammalian TrxR activity and proteasome functionality in human A431 cervical was investigated.

Novel NHC complexes of coinage metals: synthesis, cytotoxicity and solution behavior

SANTINI, Carlo;MARINELLI, MARIKA;PELLEI, Maura
2015-01-01

Abstract

N-Heterocyclic carbenes (NHCs) complexes represent new anticancer agents, normally with low toxicity profiles, and they provide a range of versatile structures for targeted biological applications [1]. In this field novel 1,3-symmetrically and 1,3-unsymmetrically substituted NHCs precursors have been synthesized (Figure 1) and used in the synthesis of multicharged metal-NHC complexes. In addition the novel NHC ligand precursor 1,4-bis(4-nitrobenzyl)-1H-1,2,4-triazol-4-ium bromide, [HTz(pNO2Bz)2]Br (Figure 1), has been synthesized and used in the synthesis of the corresponding metal complexes M[Tz(pNO2Bz)2]Br (M = Cu(I), Ag(I) or Au(I)). The cytotoxic properties of the NHCs complexes and of the corresponding uncoordinated ligands have been assessed in various human cancer cell lines, including cisplatin sensitive and resistant cells. Moreover, a detailed analysis of their molecular and cellular pharmacology has been performed in order to elucidate the role of the metallic core in determining the biological properties of this class of NHCs complexes. In particular, the ability of triazolium NHC compounds to hamper mammalian TrxR activity and proteasome functionality in human A431 cervical was investigated.
2015
273
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11581/387537
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact